Share Twitter LinkedIn Facebook Email Amy Xu, MD, Ph.D. from Memorial Sloan Kettering Cancer Center speaks about the SABCS 2021 Presentation – Oligo-progressive disease. Treating locally more than systemically.
FDA Approves Deciphera Vimseltinib / Romvimza for symptomatic tenosynovial giant cell tumor (TGCT) patients Other 2 Mins Read
FDA Approves Mirdametinib: Is this the Breakthrough NF1-PN Patients Have Been Waiting For? Other 3 Mins Read
Understanding and Managing BPDCN: Insights from Priyanka Meta’s Conference Presentation Other 2 Mins Read